FOLH1 and central nervous system cancer: Regarding the clinical findings, PET/CT with PSMA radioligands showed high diagnostic accuracy in detecting high-grade gliomas, both in discriminating high-grade gliomas from low-grade gliomas [29,30,31,32,35] and in detecting the recurrence of high-grade gliomas after treatment [29,30,33,34,36].